Inhaled nitric oxide therapy fails to improve outcome in experimental severe influenza
about
The role of myeloid cell activation and arginine metabolism in the pathogenesis of virus-induced diseasesCombinations of L-NG-monomethyl-arginine and oseltamivir against pandemic influenza A virus infections in mice.Inducible nitric oxide contributes to viral pathogenesis following highly pathogenic influenza virus infection in mice.Newer influenza antivirals, biotherapeutics and combinations.Activation of toll-like receptor signaling pathways leading to nitric oxide-mediated antiviral responses.
P2860
Inhaled nitric oxide therapy fails to improve outcome in experimental severe influenza
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Inhaled nitric oxide therapy fails to improve outcome in experimental severe influenza
@ast
Inhaled nitric oxide therapy fails to improve outcome in experimental severe influenza
@en
type
label
Inhaled nitric oxide therapy fails to improve outcome in experimental severe influenza
@ast
Inhaled nitric oxide therapy fails to improve outcome in experimental severe influenza
@en
prefLabel
Inhaled nitric oxide therapy fails to improve outcome in experimental severe influenza
@ast
Inhaled nitric oxide therapy fails to improve outcome in experimental severe influenza
@en
P2093
P2860
P356
P1476
Inhaled nitric oxide therapy fails to improve outcome in experimental severe influenza
@en
P2093
Chris Miller
Ilyse Darwish
W Conrad Liles
P2860
P304
P356
10.7150/IJMS.3880
P407
P50
P577
2012-01-13T00:00:00Z